If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
NEUROLOGY
ISSN 2054-4529 July 2014 • emjreviews.com
INSIDE
Review of
JOINT CONGRESS OF
EUROPEAN NEUROLOGY 2014
Istanbul, Turkey
CONTENTS
EDITORIAL BOARD................................................................................................................................. 4
CONGRESS REVIEW............................................................................................................................... 8
• Review of the Joint Congress of European Neurology (EFNS-ENS), held in
Istanbul, Turkey, 31st May-3rd June 2014
SYMPOSIUM REVIEWS
• Apomorphine Penject – The Emerging Evidence and Treatment Strategies for
Delayed ON and OFF Periods in Parkinson’s Disease...............
NEUROLOGY ISSN 2054-4529
CONTENTS EDITORIAL BOARD.......................
NEUROLOGY A SCARLET ENEMY OF THE BRAIN – A PRA
Editorial Board Neurology Editor-in-Chief: Dr
Welcome I am pleased to introduce to you this sec
SUBSCRIBE TO THE EMJ NEWSLETTER www.news.emjre
Foreword Dr Rita Krishnamurthi
JOINT CONGRESS OF EUROPEAN NEUROLOGY 2014 ISTANBU
Welcome to the European Medical Journal review of
JOINT CONGRESS OF EUROPEAN NEUROLOGY 2014 ISTANBU
Alzheimer’s disease (AD). Another stu
JOINT CONGRESS OF EUROPEAN NEUROLOGY 2014 ISTANBU
One biomarker more for multiple sclerosis
JOINT CONGRESS OF EUROPEAN NEUROLOGY 2014 ISTANBU
Calling for change in European regulations OPTIMU
JOINT CONGRESS OF EUROPEAN NEUROLOGY 2014 ISTANBU
Fruit flies: the key to Parkinson’s disease FRUIT
JOINT CONGRESS OF EUROPEAN NEUROLOGY 2014 ISTANBU
Neurological disorders: the underestimated threat
JOINT CONGRESS OF EUROPEAN NEUROLOGY 2014 ISTANBU
One small step in the early detection of Parkinso
JOINT CONGRESS OF EUROPEAN NEUROLOGY 2014 ISTANBU
Women suffer worse outcomes than men after stroke
JOINT CONGRESS OF EUROPEAN NEUROLOGY 2014 ISTANBU
Drug overuse top ten conditions responsible for t
JOINT CONGRESS OF EUROPEAN NEUROLOGY 2014 ISTANBU
APOMORPHINE PENJECT – EMERGING EVIDENCE AND TREAT
video evidence of real patient cases showing just
Levodopa plasma levels (ng/ml) 1400 1200 1000 80
therapeutic effect of each levodopa dose is rapid
therapies. In addition, they had never been offer
3.50 at baseline to a mean of 2.31 at the end of
Case 3 • 78-year-old male with an 18-year history
Statement APO2-0614-0489 Date of preparation: Jun
AM IMPAKT study interim results out now! Please c
THE EVOLVING MS LANDSCAPE: CHALLENGES AND OPPO
Adherence plays a crucial role in long-term
the TOWER42 studies examined teriflunomide at 7 mg
antibody. Based on the knowledge of t
and CAMMS223.67 Patients receiving alemtuzumab in
term efficacy in chronic disease: use of recursiv
reduces MS disease activity in active relaps
GE Healthcare What’s going on inside isn’t alwa
PARADIGMS: A NEW INITIATIVE TO CUT THROUGH
Table 1: The members of ParadigMS. Position N
organise by the academy or by an independent team
patients who are part of a group who meet along w
conference CME new insights p
NEUROIMAGING OF ACUTE ISCHAEMIC STROKE:
MAGNETIC RESONANCE IMAGING (MRI) IN ACUTE STROKE
MTT CBV 12.17 CTA DWI FLAIR 3h 1.56 4h 21d
2): a prospective, randomised, double- blind, pla
DEPRESSION AND PSYCHOLOGICAL DISTRESS AS
in patients younger than 65 years was 4.2-fold hi
Robinson et al.16 described that the use o
Table 1: Overview of prospective placebo-controll
ranged from 55-77 years. The effect of treatment
26. Wassertheil-Smoller S et al. Depr
IMAGING AND TREATMENT DECISIONS IN SEIZ
safe for the patient, it is also the preferred me
45 degrees. Therefore atrophy as well as signal i
Implication on Structural Lesion and Treatment De
CONCLUSION In summary, imaging in epilepsy needs
28. Wagner J et al. Morphometric MRI analysis im
A SCARLET ENEMY OF THE BRAIN – A PRACTICAL APPROA
Table 1: Causes of subarachnoid haemorrhage with
ab Figure 2: a) Gradient echo T2 scan (T2*) show
Some patients with convexal subarachnoid
It is important to recognise CAA-related inflammat
Table 2: Classic and modified Boston criteria for
Neurology. 2013;81(7):626–32. 6. Linn J et al. Pr
ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE TH
seems to be the underlying cause.10,11 Seve
picture of hypothyroidism to a certain degree of
and EEG are also required for EAATD diagnosis and
thyroiditis (SREAT) has been proposed as a
“Hashimoto’s encephalopathy”). Clin Ter. 2005;156
CURRENT CONCEPTS OF NEURODEGENERATIVE DIS
In most cases, there is an overlap and convergenc
FTD + MD
a) Extracellular deposits comprise deposits with
Table 1: Overview of neurodegenerative diseases a
4. Clinico-Neuropathological Correlations Differe
or argyrophilic grain disease (AGD) (up to 30- 40
protein deposit than from an intracellular inclus
43 pathology and hippocampal sclerosis in progres
A NOTE ON CHANGING APPROACH TO DIAGNOSIS OF ALZHE
Contrariwise, the new criteria maintain that AD-P
Table 2: National Institute of Aging and the Alzh
Conversion from prodromal at risk state to AD mig
Frequency (%) 50 40 30 20 10 0 Pre
At the other extreme of the continuum, the
Useful information comes from amyloid
Lancet Neurol. 2013;12:357-67. 25. Schneider LS.
NEUROPSYCHIATRIC FEATURES OF PARKINSON’S DI
NPS commonly exist in people with mild cognitive
MCI IN PD Until recently, there were no cle
depression was significantly more prevalent i
Table 2: Most common NPS in Parkinson’s disease w
on NPS. We have therefore summarised some o
placebo, suggesting that such interventions may h
8. Aarsland D et al. Range of neurops
MOTOR SYSTEM PLASTICITY AND COMPENSATION
kinds of adaptive changes are attributed to neura
We found the PAS-induced enhancement of
patients, but partly based on systems different f
neocortical–cerebellar functional connectivity
preclinical MS benign MS paediatric MS CIS
Compared to healthy people, MS patients may
repetitive transcranial magnetic stim
We're steadfast in our commitment to the MS commu
WHAT’S NEW Snail venom rivals morphine monopoly M
NEUROLOGY Autism: the
WHAT’S NEW Sleepers and dreamers differ in recall
NEUROLOGY Statins: the guardian of nerves BRAIN
WHAT’S NEW REST is all you need to protect from d
NEUROLOGY Headgear
WHAT’S NEW Tunnelling for Alzheimer’s cure “We c
NEUROLOGY Larger amygdalae shown to instil greate
WHAT’S NEW New treatment for alcohol-obsessed bra
NEUROLOGY Astrocytes are more than plain old vani
WHAT’S NEW Mind shock treatment zaps mentally ill
From a host of fifteen therapeutic areas, EUROPEAN
Featured Suppliers Neurology Responsible for
Buyer’s Guide Exhibitors • ACTELION PHARMACEUT
UPCOMING EVENTS Mechanisms of Epilepsy and Neuro
NEUROLOGY 44th Annual Meeting of the Society for
SUBSCRIBE TO RECEIVE THE LATEST CATIONS PUBLI